All Type of News
Chodang Pharm inks tie-up with Nihon Seiyaku
Following the Korea government's move to push for a free-trade agreement with Japan in 2006, the partnership deal between the largest wholesalers of both countries is drawing keen attention from related industries at ...
Slow in OTC drug business worsen management hardship.
The management performance of the listed drug makers having a fiscal year ended in March was remarkably depressed largely stemming from poor sale performances of the non-prescription drugs.
According to Yakup Press...
KMA and KHA jointly moving optional dispensing policy.Korea Medical Association and Korea Hospital Association gathered together at Palace hotel on May 28 to discuss an optional dispensing program earlier raised by KMA. Amid very a...
|
Korea, Japan put mutual recognition agreement on fast track
As Korea is poised to sign a free-trade agreement with Japan aimed at boosting investment and bilateral trade in 2006 at the latest, the Korea Food and Drug Administration is considering the feasibility to push for th...
Government to expand health insurance allowance benefits
The government will revise regulations to expand the coverage of the current health insurance allowance for patients with chronic disease, the Ministry of Health and Affair said recently.
The changes, which were ou...
HIRA to revise calculation criteria on medical outlays of pharmacy
The Health Insurance Review Agency said it will revise its current calculation procedures for incorporating both drug costs and dispensing charges in the medical outlays of pharmacy via several rounds of talks with th...
Wholesalers to replace foreign brand drugs with other alternatives.
The pharmaceutical wholesale community intends to replace the foreigner's monopolized brands with other alternative items.
In the city and provincial executive's meeting affiliated to the Korea Pharmaceutical Whole...
KHIDI to tie up with foreign health industrial organizations.
President Lee Kyeong-ho of KHIDI (Korea Health Industry Development Institute) visited to health industrial organizations in Switzerland and Germany including GWZ, an international economic cooperation office in Buert...
Busan KFDA 's education program for narcotic drug controls.
Busan KFDA intends to provide an educational program for about 250 narcotic drug workers at medical institutions in Busan, Ulsan and Kyeongnam province at Emergency Medical Center of Busan National Univ. hospital on J...
AstraZeneca's Crestor to challenge Pfizer's Lipitor In Korea
AstraZeneca's Crestor (rosuvastatin), which is expected to be launched during the first half of this year, will race to catch up Korea's market share, posing a threat to Pifzer's Lipitor (atorvastatin) in the antihype...
